PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.10%
Revenue growth above 1.5x NXPI's 1.06%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
6.17%
Gross profit growth above 1.5x NXPI's 2.21%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
15.50%
EBIT growth 1.25-1.5x NXPI's 12.95%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
15.25%
Operating income growth 1.25-1.5x NXPI's 12.95%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
14.66%
Net income growth at 50-75% of NXPI's 20.33%. Martin Whitman would question fundamental disadvantages in expenses or demand.
16.67%
EPS growth at 75-90% of NXPI's 20.93%. Bill Ackman would push for improved profitability or share repurchases to catch up.
16.92%
Diluted EPS growth at 75-90% of NXPI's 21.14%. Bill Ackman would expect further improvements in net income or share count reduction.
-1.40%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.52%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.30%
Dividend reduction while NXPI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
71.83%
Positive OCF growth while NXPI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
82.73%
FCF growth above 1.5x NXPI's 1.95%. David Dodd would verify if the firm’s strategic investments yield superior returns.
52.13%
10Y revenue/share CAGR above 1.5x NXPI's 31.37%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
6.46%
5Y revenue/share CAGR under 50% of NXPI's 28.59%. Michael Burry would suspect a significant competitive gap or product weakness.
12.10%
3Y revenue/share CAGR under 50% of NXPI's 39.05%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
48.23%
10Y OCF/share CAGR under 50% of NXPI's 719.76%. Michael Burry would worry about a persistent underperformance in cash creation.
24.14%
Below 50% of NXPI's 120.53%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
29.91%
3Y OCF/share CAGR under 50% of NXPI's 89.28%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
101.43%
Positive 10Y CAGR while NXPI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
7.87%
5Y net income/share CAGR above 1.5x NXPI's 0.26%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
12.80%
Below 50% of NXPI's 235.54%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
33.75%
Equity/share CAGR of 33.75% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
16.21%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-3.10%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
2216987.49%
Dividend/share CAGR of 2216987.49% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
182.59%
Dividend/share CAGR of 182.59% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
98.80%
3Y dividend/share CAGR of 98.80% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
3.28%
AR growth well above NXPI's 6.45%. Michael Burry fears inflated revenue or higher default risk in the near future.
-6.05%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-5.66%
Negative asset growth while NXPI invests at 0.70%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.92%
We have a declining book value while NXPI shows 29.04%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-15.40%
We’re deleveraging while NXPI stands at 0.06%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-1.25%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-7.66%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.